At a glance
ClinicalIndex Comparison RecordN/ACompleted· 33 enrolled
Drug / intervention
Cardiac magnetic resonance imaging (CMR)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease
In Brief
An observational study evaluating Cardiac magnetic resonance imaging (CMR) for Sickle Cell Disease. Completed, enrolled 33 participants across 1 site.
Detailed Summary
The purpose of this study is to use cardiac magnetic resonance imaging (CMR) and echocardiographic tissue Doppler imaging to demonstrate a unique restrictive cardiomyopathy of sickle cell disease. The investigators will characterize its frequency and how it might change (e.g., presence/absence and severity) over a 2-year period.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSickle Cell Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJan 2014
First PostedApr 2015
Primary CompletionJan 2018
Study CompletionMay 2019
TodayJul 2026
First PostedApr 8, 2015
Enrollment StartJan 31, 2014
Primary CompletionJan 29, 2018
Study CompletionMay 20, 2019
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 11.2 years ago
Interventions
Cardiac magnetic resonance imaging (CMR)other
CMR is obtained on all participants in all arms/groups